Sort by
Keyphrases
Astrocytic
100%
Astrocytes
58%
Glia Limitans
58%
Central Nervous System
54%
Multiple Sclerosis
51%
Visual Cortex
45%
Neuroinflammation
41%
Neurological Diseases
41%
Sham Surgery
38%
Visual Deprivation
38%
Activity-dependent Plasticity
38%
Notch1 Signaling
38%
DLK1
38%
Signaling Pathway
38%
Interleukin-6
38%
Blood-brain Barrier
36%
Visual Activity
29%
Anti-CD20 Therapy
28%
Experimental Autoimmune Encephalomyelitis
27%
Perivascular Spaces
27%
Gene Expression
26%
Autoimmune Disease
25%
Blood-brain Barrier Opening
25%
Junctional Adhesion Molecule
24%
Tumor-infiltrating Immune Cells
23%
Reactive Astrocytes
22%
Immunomodulatory Therapy
22%
Transcriptional Repressor
21%
Monocytes
21%
Inflammatory Diseases
20%
Primary Visual Cortex V1
20%
Healthy Controls
20%
Placebo-controlled
19%
Clinical Trials
19%
Placebo
19%
CNS Myelination
19%
Tight Junction
19%
Gene Expression Changes
19%
Actin Binding
19%
Lateral Geniculate nucleus
19%
Immunological Response
19%
Differential Gene Expression
19%
7T MRI
19%
Central Nervous System Lesions
19%
Cell Entry
19%
Path Development
19%
Successful Treatment
19%
Auditory Pathway
19%
T Cells
19%
Gene Expression Pattern
19%
Neuroscience
Astrocyte
76%
Blood Brain Barrier
59%
Gene Expression
58%
Visual Cortex
58%
Glia limitans
38%
Interleukin 6
38%
Cell Signaling
38%
STAT3
38%
Ocular Dominance
35%
Central Nervous System
29%
Nervous System Disorder
27%
Myelinogenesis
25%
Lateral Geniculate Nucleus
24%
Tight Junction
24%
Magnetic Resonance Imaging
22%
Thalamus
21%
Multiple Sclerosis
20%
Medial Geniculate Nucleus
19%
Recombinant Interleukin 7
19%
Blood Clotting Factor 6
19%
Susceptibility Weighted Imaging
19%
Parvalbumin
19%
Insulin-Like Growth Factor 1
19%
Auditory Cortex
19%
Placebo
19%
Actin
19%
Vasculotropin A
19%
Progressive Multifocal Leukoencephalopathy
19%
Lymphocytopenia
19%
CD4
19%
Maraviroc
19%
Neuroscience
19%
Visual Deprivation
19%
DNA Microarray
16%
In Vivo
14%
Immunohistochemistry
14%
Glycoprotein Gp 130
13%
Interleukin 7
13%
Growth Factor
12%
Nucleus
12%
Leukocyte
9%
Synaptic Transmission
9%
Protein Binding
9%
Parkinson's Disease
9%
Nerve Cell Degeneration
9%
Interneuron
9%
Oligodendrocyte Progenitor
8%
Karyopherin
8%
Angiogenesis
7%
Experimental Autoimmune Encephalomyelitis
7%
Medicine and Dentistry
Neurologic Disease
31%
Autoimmune Disease
29%
CD20
28%
COVID-19
22%
Multiple Sclerosis
21%
Lymphocytopenia
21%
Placebo
19%
Clinical Trial
19%
Receptor
19%
Progressive Multifocal Leukoencephalopathy
19%
Maraviroc
19%
Blood Clotting Factor 6
19%
Myelination
19%
Recombinant Interleukin 7
19%
Transcriptional Activator
19%
Dietary Intake
19%
Antibody Response
19%
COVID-19 Vaccine
19%
Caloric Intake
19%
Inflammatory Disorder
19%
Sphingosine
19%
Astrocyte
19%
Drive
19%
Norfloxacin
19%
Immunocompetent Cell
19%
Central Nervous System
19%
Peripheral Nervous System
19%
Sphingosine 1 Phosphate Receptor
17%
Neutralizing Antibody
14%
Glycoprotein Gp 130
13%
Interleukin 7
13%
Oligodendrocyte
11%
Experimental Autoimmune Encephalomyelitis
11%
Disease Modifying Therapy
10%
Parkinson's Disease
9%
Clinical Trial Design
9%
Peroxisome Proliferator-Activated Receptor
9%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
9%
Caloric Restriction
9%
Protein Intake
9%
Hepatocyte
9%
Glucose Intake
9%
Tissue Repair
9%
Alpha Adrenergic Receptor
9%
Dietary Habit
9%
Karyopherin
8%
B Cell
6%
Tamoxifen
5%
JC Virus
5%
Maturation
5%
